Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety.
Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.